6 products found
Pharmigene, Inc. Products
-
Pharmigene - Molecular Diagnostics
A simple genetic test can personalize medicine for you and reduce adverse drug reactions?. Adverse Drug Reactions (ADR) describe injurious effects associated with therapeutic drugs at normal dose. Some adverse drug reactions are not very serious, but others cause death, prolong hospitalization, and permanent disability. Millions of people are affected by ADR in the world each year. Although most adverse drug events can be avoided with attentive patient care, some adverse events are difficult to detect or to prevent in a timely manner. More than 1 million Americans are hospitalized due to ADR each year.
-
Pharmigene - Model HLA-B*1502 - Carbamazepine & Phenytoin RT-PCR & SYBR Green Based Detection Kit
RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of Human Leukocyte Antigen (HLA-B*1502) and Internal Control. Analysis is based on Ct values. A complete kit version has IVD approval from Department of Health, ...
-
Pharmigene - Model HLA-B*5701 - RT-PCR & SYBR Green Based Detection Kit
RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-B*5701 and Internal Control. Analysis is based on Ct ...
-
Pharmigene - Model HLA-B*5801 - RT-PCR & SYBR Green Based Detection Kit
RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-B*5801 and Internal Control. Analysis is based on Ct values. A complete kit version has IVD approval from Department of Health, ...
-
Pharmigene - Model HLA-B*27 - RT-PCR & SYBR Green Based Detection Kit
RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-B*27 and Internal Control. Analysis is based on Ct ...
-
Pharmigene - Model CYP2C19*2 & *3 - Detection Kit (RUO)
Clodpgrel, an antiplatelet agents is indicated for the reduction of thrombotic events as follows: Recent MI, Recent Stroke or Established Peripheral Arterial Disease. For patients with a history of recent myocardial infarction (MI), recent stroke, or established peripheral arterial disease, Clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new MI (fatal or not), and other vascular ...
-
Pharmigene - Model UGT1A1*28 - Detection (Testing Service) Kit
UGT1A1 gene promoter usually have 5-8 TA repeat, most people with 6/6 TA repeat, few people are 6/7 or 7/7 TA repeat, 7 TA repeat genotypes were named for the ...